Table 3.
Multivariate analysis of clinical factors associated with preoperative serum miR-200a. *P<0.05.
| Factors | B | SE | Wald | df | P | EXP(B) | 95% CI | |
|---|---|---|---|---|---|---|---|---|
| Upper limit | Lower limit | |||||||
| Tumor size: >5 cm vs ≤5 cm | -1.643 | 0.078 | 1.004 | 1 | 0.063 | 0.193 | 0.518 | 0.212 |
| TNM stage: 0-II vs III-IV | -1.159 | 0.115 | 0.012 | 1 | 0.120 | 0.314 | 0.590 | 0.223 |
| Differentiation: middle vs poor | 0.715 | 0.018 | 2.054 | 1 | 0.051 | 2.044 | 0.401 | 0.035 |
| Metastasis: yes vs no | -0.536 | 0.072 | 4.351 | 1 | 0.032* | 0.029 | 0.506 | 0.141 |
| Recurrence: yes vs no | -2.285 | 0.034 | 3.008 | 1 | 0.028* | 0.001 | 0.432 | 0.067 |